Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.27 USD | -2.93% | -8.19% | +10.30% |
22/05 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
14/05 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.30% | 776.36Cr | |
+10.79% | 12TCr | |
+11.65% | 11TCr | |
-6.20% | 2.47TCr | |
-2.33% | 2.2TCr | |
-6.03% | 1.93TCr | |
-13.41% | 1.76TCr | |
-40.50% | 1.73TCr | |
+6.64% | 1.4TCr | |
+31.84% | 1.21TCr |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte, Lonza Sign Vaccine Manufacturing Agreement